• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Characterization of poliovirus-specific T lymphocytes in the peripheral blood of Sabin-vaccinated humans.脊髓灰质炎疫苗接种者外周血中脊髓灰质炎病毒特异性T淋巴细胞的特征分析
J Virol. 1993 Mar;67(3):1262-8. doi: 10.1128/JVI.67.3.1262-1268.1993.
2
Identification of T-helper epitopes in the VP1 capsid protein of poliovirus.脊髓灰质炎病毒VP1衣壳蛋白中T辅助细胞表位的鉴定
J Virol. 1992 May;66(5):3042-7. doi: 10.1128/JVI.66.5.3042-3047.1992.
3
Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: identification of T helper epitopes in VP1.猪T细胞针对口蹄疫病毒结构蛋白的抗原特异性:VP1中T辅助表位的鉴定
Virology. 1994 Nov 15;205(1):24-33. doi: 10.1006/viro.1994.1616.
4
Antigenic sequences of poliovirus recognized by T cells: serotype-specific epitopes on VP1 and VP3 and cross-reactive epitopes on VP4 defined by using CD4+ T-cell clones.T细胞识别的脊髓灰质炎病毒抗原序列:利用CD4 + T细胞克隆确定的VP1和VP3上的血清型特异性表位以及VP4上的交叉反应表位
J Virol. 1992 Dec;66(12):7012-20. doi: 10.1128/JVI.66.12.7012-7020.1992.
5
Immunodominant T-cell epitopes of rubella virus structural proteins defined by synthetic peptides.由合成肽确定的风疹病毒结构蛋白的免疫显性T细胞表位
J Virol. 1993 Feb;67(2):673-81. doi: 10.1128/JVI.67.2.673-681.1993.
6
Interspecies major histocompatibility complex-restricted Th cell epitope on foot-and-mouth disease virus capsid protein VP4.口蹄疫病毒衣壳蛋白VP4上的种间主要组织相容性复合体限制的Th细胞表位
J Virol. 2000 May;74(10):4902-7. doi: 10.1128/jvi.74.10.4902-4907.2000.
7
Poliovirus Sabin type 1 neutralization epitopes recognized by immunoglobulin A monoclonal antibodies.脊髓灰质炎病毒1型萨宾株被免疫球蛋白A单克隆抗体识别的中和表位
J Virol. 1997 Sep;71(9):6905-12. doi: 10.1128/JVI.71.9.6905-6912.1997.
8
A study of the cellular immune response to enteroviruses in humans: identification of cross-reactive T cell epitopes on the structural proteins of enteroviruses.一项关于人类对肠道病毒细胞免疫反应的研究:肠道病毒结构蛋白上交叉反应性T细胞表位的鉴定
J Gen Virol. 1996 Sep;77 ( Pt 9):2097-108. doi: 10.1099/0022-1317-77-9-2097.
9
New virus-specific T-helper epitopes of foot-and-mouth disease viral VP1 protein.口蹄疫病毒VP1蛋白新的病毒特异性T辅助表位
FEBS Lett. 1993 Oct 25;333(1-2):175-8. doi: 10.1016/0014-5793(93)80399-f.
10
VP2 dominated CD4+ T cell responses against enterovirus 71 and cross-reactivity against coxsackievirus A16 and polioviruses in a healthy population.在健康人群中,VP2 主导针对肠道病毒 71 型的 CD4+ T 细胞反应,并与柯萨奇病毒 A16 和脊髓灰质炎病毒发生交叉反应。
J Immunol. 2013 Aug 15;191(4):1637-47. doi: 10.4049/jimmunol.1301439. Epub 2013 Jul 17.

引用本文的文献

1
Oral live attenuated polio vaccines induce enhanced T-cell responses with broad antigen recognition compared to inactivated polio vaccines.与灭活脊髓灰质炎疫苗相比,口服减毒活脊髓灰质炎疫苗可诱导具有广泛抗原识别能力的增强型T细胞反应。
medRxiv. 2025 May 21:2025.05.20.25328004. doi: 10.1101/2025.05.20.25328004.
2
Enterovirus D68 molecular and cellular biology and pathogenesis.肠道病毒 D68 的分子、细胞生物学与发病机制。
J Biol Chem. 2021 Jan-Jun;296:100317. doi: 10.1016/j.jbc.2021.100317. Epub 2021 Jan 21.
3
T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.T 淋巴细胞作为针对病毒疾病的保护和疫苗接种的可衡量靶标。
Int Rev Cell Mol Biol. 2019;342:175-263. doi: 10.1016/bs.ircmb.2018.07.006. Epub 2018 Oct 24.
4
Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.针对小核糖核酸病毒的先天性和适应性免疫反应及其对抗作用:综述。
World J Virol. 2012 Jun 12;1(3):91-107. doi: 10.5501/wjv.v1.i3.91.
5
Virus-specific CD4+ and CD8+ cytotoxic T-cell responses and long-term T-cell memory in individuals vaccinated against polio.接种脊髓灰质炎疫苗个体中的病毒特异性CD4+和CD8+细胞毒性T细胞反应及长期T细胞记忆
J Virol. 2005 May;79(10):5988-95. doi: 10.1128/JVI.79.10.5988-5995.2005.
6
Dendritic cells and macrophages are productively infected by poliovirus.树突状细胞和巨噬细胞可被脊髓灰质炎病毒有效感染。
J Virol. 2005 Jan;79(1):401-9. doi: 10.1128/JVI.79.1.401-409.2005.
7
Antibody responses to antigenic sites 1 and 3 of serotype 3 poliovirus after vaccination with oral live attenuated or inactivated poliovirus vaccine and after natural exposure.口服减毒活脊髓灰质炎病毒疫苗或灭活脊髓灰质炎病毒疫苗接种后以及自然暴露后,针对3型脊髓灰质炎病毒抗原位点1和3的抗体反应。
Clin Diagn Lab Immunol. 2000 Jan;7(1):40-4. doi: 10.1128/CDLI.7.1.40-44.2000.
8
Mucosal immunization of cynomolgus macaques with two serotypes of live poliovirus vectors expressing simian immunodeficiency virus antigens: stimulation of humoral, mucosal, and cellular immunity.用两种表达猿猴免疫缺陷病毒抗原的活脊髓灰质炎病毒载体对食蟹猴进行黏膜免疫:体液、黏膜和细胞免疫的刺激
J Virol. 1999 Nov;73(11):9485-95. doi: 10.1128/JVI.73.11.9485-9495.1999.
9
Lymphoproliferative responses after infection with human parvovirus B19.人细小病毒B19感染后的淋巴细胞增殖反应。
J Virol. 1996 Oct;70(10):7327-30. doi: 10.1128/JVI.70.10.7327-7330.1996.
10
Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag.从感染了表达1型人类免疫缺陷病毒(HIV-1)Gag的脊髓灰质炎病毒复制子的细胞中释放病毒样颗粒。
J Virol. 1996 Apr;70(4):2643-9. doi: 10.1128/JVI.70.4.2643-2649.1996.

本文引用的文献

1
Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome.减毒脊髓灰质炎病毒萨宾1型毒株基因组的完整核苷酸序列。
Proc Natl Acad Sci U S A. 1982 Oct;79(19):5793-7. doi: 10.1073/pnas.79.19.5793.
2
Isolated poliovirus capsid protein VP1 induces a neutralizing response in rats.分离出的脊髓灰质炎病毒衣壳蛋白VP1在大鼠体内诱导产生中和反应。
Proc Natl Acad Sci U S A. 1982 Dec;79(23):7518-21. doi: 10.1073/pnas.79.23.7518.
3
A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules.II类组织相容性分子的外来抗原结合位点的假设模型。
Nature. 1988 Apr 28;332(6167):845-50. doi: 10.1038/332845a0.
4
Modulation of humoral response to a 12-amino-acid site on the poliovirus virion.对脊髓灰质炎病毒病毒体上一个12氨基酸位点的体液反应调节
J Virol. 1986 Oct;60(1):297-301. doi: 10.1128/JVI.60.1.297-301.1986.
5
Trypsin sensitivity of the Sabin strain of type 1 poliovirus: cleavage sites in virions and related particles.1型脊髓灰质炎病毒萨宾株的胰蛋白酶敏感性:病毒体及相关颗粒中的切割位点
J Virol. 1985 Jun;54(3):856-9. doi: 10.1128/JVI.54.3.856-859.1985.
6
Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies.来自脊髓灰质炎病毒1型衣壳蛋白VP1四个不同区域的合成肽可诱导中和抗体。
Proc Natl Acad Sci U S A. 1985 Feb;82(3):910-4. doi: 10.1073/pnas.82.3.910.
7
Cleavage of VP1 and modification of antigenic site 1 of type 2 polioviruses by intestinal trypsin.肠道胰蛋白酶对2型脊髓灰质炎病毒VP1的切割及抗原位点1的修饰
J Virol. 1988 Sep;62(9):3536-9. doi: 10.1128/JVI.62.9.3536-3539.1988.
8
Intestinal trypsin can significantly modify antigenic properties of polioviruses: implications for the use of inactivated poliovirus vaccine.肠道胰蛋白酶可显著改变脊髓灰质炎病毒的抗原特性:对灭活脊髓灰质炎病毒疫苗使用的启示。
J Virol. 1987 Dec;61(12):3749-53. doi: 10.1128/JVI.61.12.3749-3753.1987.
9
Anti-thymocyte serum delays clearance of poliovirus from the mouse central nervous system.
J Neuroimmunol. 1989 May;22(3):223-32. doi: 10.1016/0165-5728(89)90020-9.
10
Cell-mediated immune responses to poliovirus. I. Conditions for induction, characterization of effector cells, and cross-reactivity between serotypes for delayed hypersensitivity and T cell proliferative responses.针对脊髓灰质炎病毒的细胞介导免疫反应。I. 诱导条件、效应细胞的特征以及血清型之间迟发型超敏反应和T细胞增殖反应的交叉反应性。
Cell Immunol. 1989 Apr 1;119(2):252-62. doi: 10.1016/0008-8749(89)90242-6.

脊髓灰质炎疫苗接种者外周血中脊髓灰质炎病毒特异性T淋巴细胞的特征分析

Characterization of poliovirus-specific T lymphocytes in the peripheral blood of Sabin-vaccinated humans.

作者信息

Simons J, Kutubuddin M, Chow M

机构信息

Department of Applied Biological Sciences, Massachusetts Institute of Technology, Cambridge 02139-4307.

出版信息

J Virol. 1993 Mar;67(3):1262-8. doi: 10.1128/JVI.67.3.1262-1268.1993.

DOI:10.1128/JVI.67.3.1262-1268.1993
PMID:7679744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC237492/
Abstract

Poliovirus-specific cellular immune responses were identified in the peripheral blood mononucleocytes of Sabin-immunized human donors by using a proliferation assay. Complement depletion and monoclonal antibody inhibition studies suggest that the effector population is the major histocompatibility complex (MHC) class II-restricted CD4+ T-helper cell. Immune lymphocytes proliferated to polyacrylamide gel purified-capsid proteins VP1, VP2, and VP3 and, in some individuals, to synthetic VP4, indicating the presence of T-cell epitopes in each of these proteins. Using synthetic peptides, T-cell epitopes have been mapped to specific regions in VP1 which lie near previously identified neutralizing antibody recognition sites. Human leukocyte antigen (HLA) typing of the donor individuals indicated that no MHC class II molecule was held in common between all four donor individuals. Thus, the positive responses observed with peptides p182-201 and p244-261 in three of four and four of four donors suggest that these peptides contain epitopes presented by at least two different MHC molecules. Antibody-blocking experiments suggest that an epitope within VP1 residues 244 to 264 is presented by HLA DQ3.

摘要

通过增殖试验在接受萨宾疫苗免疫的人类供体的外周血单核细胞中鉴定出脊髓灰质炎病毒特异性细胞免疫反应。补体耗竭和单克隆抗体抑制研究表明,效应细胞群体是主要组织相容性复合体(MHC)II类限制性CD4 + T辅助细胞。免疫淋巴细胞对聚丙烯酰胺凝胶纯化的衣壳蛋白VP1、VP2和VP3增殖,在一些个体中对合成的VP4增殖,表明这些蛋白中均存在T细胞表位。使用合成肽,已将T细胞表位定位到VP1中靠近先前确定的中和抗体识别位点的特定区域。供体个体的人类白细胞抗原(HLA)分型表明,所有四个供体个体之间没有共同的MHC II类分子。因此,在四个供体中的三个和四个供体中的四个中观察到的肽p182 - 201和p244 - 261的阳性反应表明,这些肽包含由至少两种不同MHC分子呈递的表位。抗体阻断实验表明,VP1残基244至264内的一个表位由HLA DQ3呈递。